Ultragenyx Pharmaceutical SG&A Expense (Quarterly) Insights

Ultragenyx Pharmaceutical Inc (RARE)

41.90 -0.71 (-1.67%) USD | NASDAQ | May 17, 16:00

41.90 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
March 31, 2024	78.16M
December 31, 2023	76.83M
September 30, 2023	74.92M
June 30, 2023	81.40M
March 31, 2023	76.65M
December 31, 2022	72.85M
September 30, 2022	69.84M
June 30, 2022	68.14M
March 31, 2022	67.31M
December 31, 2021	59.43M
September 30, 2021	53.88M
June 30, 2021	53.41M
March 31, 2021	53.26M
December 31, 2020	51.04M
September 30, 2020	42.12M
June 30, 2020	42.25M
March 31, 2020	47.52M
December 31, 2019	41.88M
September 30, 2019	41.01M
June 30, 2019	39.81M
March 31, 2019	38.83M
December 31, 2018	34.48M
September 30, 2018	31.10M

Date	Value
June 30, 2018	30.72M
March 31, 2018	31.44M
December 31, 2017	37.72M
September 30, 2017	23.50M
June 30, 2017	20.00M
March 31, 2017	18.68M
December 31, 2016	19.81M
September 30, 2016	17.18M
June 30, 2016	14.74M
March 31, 2016	13.21M
December 31, 2015	11.59M
September 30, 2015	10.23M
June 30, 2015	7.038M
March 31, 2015	4.138M
December 31, 2014	3.422M
September 30, 2014	2.981M
June 30, 2014	2.422M
March 31, 2014	1.986M
December 31, 2013	1.321M
September 30, 2013	0.999M
June 30, 2013	1.048M
March 31, 2013	1.083M
December 31, 2012	0.903M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

39.81M

Minimum

Jun 2019

81.40M

Maximum

Jun 2023

59.59M

Average

56.66M

Median

SG&A Expense (Quarterly) Benchmarks